SG10201912621TA - Cell culture compositions with antioxidants and methods for polypeptide production - Google Patents

Cell culture compositions with antioxidants and methods for polypeptide production

Info

Publication number
SG10201912621TA
SG10201912621TA SG10201912621TA SG10201912621TA SG10201912621TA SG 10201912621T A SG10201912621T A SG 10201912621TA SG 10201912621T A SG10201912621T A SG 10201912621TA SG 10201912621T A SG10201912621T A SG 10201912621TA SG 10201912621T A SG10201912621T A SG 10201912621TA
Authority
SG
Singapore
Prior art keywords
antioxidants
methods
cell culture
polypeptide production
culture compositions
Prior art date
Application number
SG10201912621TA
Inventor
Natarajan Vijayasankaran
Steven Meier
Sharat Varma
Yi Yang
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=50639996&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG10201912621T(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of SG10201912621TA publication Critical patent/SG10201912621TA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/32—Amino acids
    • C12N2500/33—Amino acids other than alpha-amino carboxylic acids, e.g. beta-amino acids, taurine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/44—Thiols, e.g. mercaptoethanol
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/46—Amines, e.g. putrescine
SG10201912621TA 2013-03-15 2014-03-14 Cell culture compositions with antioxidants and methods for polypeptide production SG10201912621TA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201361799602P 2013-03-15 2013-03-15

Publications (1)

Publication Number Publication Date
SG10201912621TA true SG10201912621TA (en) 2020-02-27

Family

ID=50639996

Family Applications (3)

Application Number Title Priority Date Filing Date
SG11201507367PA SG11201507367PA (en) 2013-03-15 2014-03-14 Cell culture compositions with antioxidants and methods for polypeptide production
SG10201912621TA SG10201912621TA (en) 2013-03-15 2014-03-14 Cell culture compositions with antioxidants and methods for polypeptide production
SG10201809452RA SG10201809452RA (en) 2013-03-15 2014-03-14 Cell culture compositions with antioxidants and methods for polypeptide production

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SG11201507367PA SG11201507367PA (en) 2013-03-15 2014-03-14 Cell culture compositions with antioxidants and methods for polypeptide production

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG10201809452RA SG10201809452RA (en) 2013-03-15 2014-03-14 Cell culture compositions with antioxidants and methods for polypeptide production

Country Status (19)

Country Link
US (5) US10017732B2 (en)
EP (2) EP2970875B1 (en)
JP (2) JP6591395B2 (en)
KR (2) KR20210037745A (en)
CN (2) CN105121628B (en)
AU (3) AU2014233393B2 (en)
BR (1) BR112015021993A8 (en)
CA (1) CA2903596C (en)
ES (1) ES2798307T3 (en)
HK (1) HK1218141A1 (en)
HR (1) HRP20200893T1 (en)
IL (2) IL240644B (en)
MX (2) MX360779B (en)
PL (1) PL2970875T3 (en)
RU (2) RU2718986C2 (en)
SG (3) SG11201507367PA (en)
SI (1) SI2970875T1 (en)
WO (1) WO2014145098A1 (en)
ZA (2) ZA201506155B (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112015021993A8 (en) 2013-03-15 2019-12-03 Genentech Inc polypeptide, methods for producing it, methods for culturing a cell, pharmaceutical composition, kit, and cell culture medium
US9416181B2 (en) * 2013-05-06 2016-08-16 Abbvie Inc. Compositions for cell culture and methods of using the same
MA40864A (en) * 2014-10-31 2017-09-05 Biogen Ma Inc HYPOTAURINE, GABA, BETA-ALANINE AND CHOLINE FOR THE REGULATION OF THE ACCUMULATION OF RESIDUAL BY-PRODUCTS IN MAMMAL CELL CULTURE PROCESSES
TW202330904A (en) 2015-08-04 2023-08-01 美商再生元醫藥公司 Taurine supplemented cell culture medium and methods of use
US11186858B1 (en) 2016-03-15 2021-11-30 Fresenius Kabi Deutschland Gmbh Methods for increasing biosimilarity
US11254964B1 (en) * 2016-03-15 2022-02-22 Fresenius Kabi Deutschland Gmbh Cell culture methods for increased cell viability
KR20190005966A (en) 2016-05-10 2019-01-16 제넨테크, 인크. Methods for reducing trisulfide bonds during recombinant production of polypeptides
CN106070537A (en) * 2016-07-08 2016-11-09 广东海洋大学 A kind of antioxidant suppressing the black change of shrimp and preparation method and application
US20210403971A1 (en) * 2018-11-02 2021-12-30 Kyowa Kirin Co., Ltd. Method for preparing liquid medium
HUP1800376A2 (en) * 2018-11-07 2020-05-28 Richter Gedeon Nyrt Method for modifying the glycosylation profile of a recombinant glycoprotein produced in cell culture
NZ781143A (en) 2019-12-06 2023-05-26 Regeneron Pharma Anti-vegf protein compositions and methods for producing the same
WO2023194946A1 (en) * 2022-04-06 2023-10-12 Kashiv Biosciences, Llc An improved cell culture process for production of protein

Family Cites Families (105)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE266710C (en)
US3883511A (en) 1974-03-07 1975-05-13 Rit Rech Ind Therapeut New 6-aminopenicillanic acid derivative
USRE30985E (en) 1978-01-01 1982-06-29 Serum-free cell culture media
FR2413974A1 (en) 1978-01-06 1979-08-03 David Bernard DRYER FOR SCREEN-PRINTED SHEETS
US4419446A (en) 1980-12-31 1983-12-06 The United States Of America As Represented By The Department Of Health And Human Services Recombinant DNA process utilizing a papilloma virus DNA as a vector
NZ201705A (en) 1981-08-31 1986-03-14 Genentech Inc Recombinant dna method for production of hepatitis b surface antigen in yeast
US4601978A (en) 1982-11-24 1986-07-22 The Regents Of The University Of California Mammalian metallothionein promoter system
US4560655A (en) 1982-12-16 1985-12-24 Immunex Corporation Serum-free cell culture medium and process for making same
US4657866A (en) 1982-12-21 1987-04-14 Sudhir Kumar Serum-free, synthetic, completely chemically defined tissue culture media
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
DD266710A3 (en) 1983-06-06 1989-04-12 Ve Forschungszentrum Biotechnologie Process for the biotechnical production of alkaline phosphatase
US4767704A (en) 1983-10-07 1988-08-30 Columbia University In The City Of New York Protein-free culture medium
US4965199A (en) 1984-04-20 1990-10-23 Genentech, Inc. Preparation of functional human factor VIII in mammalian cells using methotrexate based selection
US4879231A (en) 1984-10-30 1989-11-07 Phillips Petroleum Company Transformation of yeasts of the genus pichia
GB8516415D0 (en) 1985-06-28 1985-07-31 Celltech Ltd Culture of animal cells
US4676980A (en) 1985-09-23 1987-06-30 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Target specific cross-linked heteroantibodies
US4927762A (en) 1986-04-01 1990-05-22 Cell Enterprises, Inc. Cell culture medium with antioxidant
GB8610600D0 (en) 1986-04-30 1986-06-04 Novo Industri As Transformation of trichoderma
IL87737A (en) 1987-09-11 1993-08-18 Genentech Inc Method for culturing polypeptide factor dependent vertebrate recombinant cells
CA1338518C (en) 1987-09-23 1996-08-13 Joyce M. Zarling Antibody heteroconjugates for the killing of hiv-infected cells
EP0435911B1 (en) 1988-09-23 1996-03-13 Cetus Oncology Corporation Cell culture medium for enhanced cell growth, culture longevity and product expression
GB8823869D0 (en) 1988-10-12 1988-11-16 Medical Res Council Production of antibodies
EP0368684B2 (en) 1988-11-11 2004-09-29 Medical Research Council Cloning immunoglobulin variable domain sequences.
FR2646437B1 (en) 1989-04-28 1991-08-30 Transgene Sa NOVEL DNA SEQUENCES, THEIR APPLICATION AS A SEQUENCE ENCODING A SIGNAL PEPTIDE FOR THE SECRETION OF MATURE PROTEINS BY RECOMBINANT YEASTS, EXPRESSION CASSETTES, PROCESSED YEASTS AND PROCESS FOR PREPARING THE SAME
EP0402226A1 (en) 1989-06-06 1990-12-12 Institut National De La Recherche Agronomique Transformation vectors for yeast yarrowia
ES2096590T3 (en) 1989-06-29 1997-03-16 Medarex Inc BI-SPECIFIC REAGENTS FOR AIDS THERAPY.
US5959177A (en) 1989-10-27 1999-09-28 The Scripps Research Institute Transgenic plants expressing assembled secretory antibodies
ATE139258T1 (en) 1990-01-12 1996-06-15 Cell Genesys Inc GENERATION OF XENOGENE ANTIBODIES
JP3230091B2 (en) 1990-06-25 2001-11-19 ウェルファイド株式会社 Method for suppressing coloration of human serum albumin
US5661016A (en) 1990-08-29 1997-08-26 Genpharm International Inc. Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
US5625126A (en) 1990-08-29 1997-04-29 Genpharm International, Inc. Transgenic non-human animals for producing heterologous antibodies
EP0546073B1 (en) 1990-08-29 1997-09-10 GenPharm International, Inc. production and use of transgenic non-human animals capable of producing heterologous antibodies
US5633425A (en) 1990-08-29 1997-05-27 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
US5545806A (en) 1990-08-29 1996-08-13 Genpharm International, Inc. Ransgenic non-human animals for producing heterologous antibodies
US5122469A (en) 1990-10-03 1992-06-16 Genentech, Inc. Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins
WO1992009298A1 (en) * 1990-11-23 1992-06-11 Peptide Technology Ltd. The delay, prevention and/or reversal of cell senescence
DK0564531T3 (en) 1990-12-03 1998-09-28 Genentech Inc Enrichment procedure for variant proteins with altered binding properties
US5571894A (en) 1991-02-05 1996-11-05 Ciba-Geigy Corporation Recombinant antibodies specific for a growth factor receptor
EP0586505A1 (en) 1991-05-14 1994-03-16 Repligen Corporation Heteroconjugate antibodies for treatment of hiv infection
CA2116774C (en) 1991-09-19 2003-11-11 Paul J. Carter Expression in e. coli antibody fragments having at least a cysteine present as a free thiol. use for the production of bifunctional f(ab') 2 antibodies
WO1993006213A1 (en) 1991-09-23 1993-04-01 Medical Research Council Production of chimeric antibodies - a combinatorial approach
US5587458A (en) 1991-10-07 1996-12-24 Aronex Pharmaceuticals, Inc. Anti-erbB-2 antibodies, combinations thereof, and therapeutic and diagnostic uses thereof
WO1993008829A1 (en) 1991-11-04 1993-05-13 The Regents Of The University Of California Compositions that mediate killing of hiv-infected cells
US5667988A (en) 1992-01-27 1997-09-16 The Scripps Research Institute Methods for producing antibody libraries using universal or randomized immunoglobulin light chains
CA2372813A1 (en) 1992-02-06 1993-08-19 L.L. Houston Biosynthetic binding protein for cancer marker
JPH07507446A (en) * 1992-03-04 1995-08-24 シナプティック・ファーマスーティカル・コーポレーション DNA encoding taurine and GABA transporter and its use
JPH07102147B2 (en) 1992-03-16 1995-11-08 株式会社ミドリ十字 Method for suppressing coloration of human serum albumin
DE69308573T2 (en) 1992-08-17 1997-08-07 Genentech Inc SPECIFIC IMMUNOADHESINE
JP3095175B2 (en) 1992-11-13 2000-10-03 アイデック ファーマシューティカルズ コーポレイション Therapeutic use of chimeric and radiolabeled antibodies against human B lymphocyte restricted differentiation antigen for the treatment of B cell lymphoma
US5856179A (en) 1994-03-10 1999-01-05 Genentech, Inc. Polypeptide production in animal cell culture
US5789199A (en) 1994-11-03 1998-08-04 Genentech, Inc. Process for bacterial production of polypeptides
US5840523A (en) 1995-03-01 1998-11-24 Genetech, Inc. Methods and compositions for secretion of heterologous polypeptides
US5731168A (en) 1995-03-01 1998-03-24 Genentech, Inc. Method for making heteromultimeric polypeptides
US5641870A (en) 1995-04-20 1997-06-24 Genentech, Inc. Low pH hydrophobic interaction chromatography for antibody purification
US5869046A (en) 1995-04-14 1999-02-09 Genentech, Inc. Altered polypeptides with increased half-life
JP4312259B2 (en) 1995-04-27 2009-08-12 アムジェン フレモント インク． Human antibodies derived from immunized XenoMouse
AU2466895A (en) 1995-04-28 1996-11-18 Abgenix, Inc. Human antibodies derived from immunized xenomice
US6267958B1 (en) 1995-07-27 2001-07-31 Genentech, Inc. Protein formulation
KR100643058B1 (en) 1996-12-03 2006-11-13 아브게닉스, 인크. Transgenic mammals having human ig loci including plural vh and vk regions and antibodies produced therefrom
US20080318254A9 (en) 1997-03-10 2008-12-25 The Regents Of The University Of California PSCA antibodies and hybridomas producing them
US20020012991A1 (en) * 1997-04-07 2002-01-31 Florence Chua Nee Ho Kit Fong Cell culture media for enhanced protein production
US20020173629A1 (en) 1997-05-05 2002-11-21 Aya Jakobovits Human monoclonal antibodies to epidermal growth factor receptor
US6171586B1 (en) 1997-06-13 2001-01-09 Genentech, Inc. Antibody formulation
AU7984498A (en) * 1997-06-25 1999-01-04 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Serum-free cell growth medium
US6040498A (en) 1998-08-11 2000-03-21 North Caroline State University Genetically engineered duckweed
US6610833B1 (en) 1997-11-24 2003-08-26 The Institute For Human Genetics And Biochemistry Monoclonal human natural antibodies
WO2000058499A1 (en) 1999-03-30 2000-10-05 Japan Tobacco Inc. Process for producing monoclonal antibody
MXPA02003456A (en) 1999-10-04 2002-10-23 Medicago Inc Method for regulating transcription of foreign genes in the presence of nitrogen.
US7125978B1 (en) 1999-10-04 2006-10-24 Medicago Inc. Promoter for regulating expression of foreign genes
RU2192884C2 (en) * 2000-11-09 2002-11-20 Государственное учреждение Научно-исследовательский институт клинической иммунологии СО РАМН Vaccine for antitumor immunity stimulation
US7311905B2 (en) * 2002-02-13 2007-12-25 Anthrogenesis Corporation Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells
JP2005519580A (en) 2001-05-16 2005-07-07 アルバート アインシュタイン カレッジ オブ メディシン オブ イエシバ ユニバーシティ Human anti-pneumococcal antibody derived from non-human animals
AU2002316230A1 (en) 2001-06-13 2002-12-23 Genentech, Inc. Methods of culturing animal cells and polypeptide production in animal cells
CA2456648C (en) 2001-08-23 2011-08-16 Genmab A/S Human antibodies specific for interleukin 15 (il-15)
US7371922B2 (en) * 2002-07-31 2008-05-13 The Board Of Trustees Of The University Of Illinois Nuclear transfer with porcine embryonic stem cells
ES2347241T3 (en) 2002-12-16 2010-10-27 Genentech, Inc. VARIATIONS OF IMMUNOGLOBULIN AND ITS USES.
AU2003299641C1 (en) 2002-12-16 2016-06-02 Cormorant Pharmaceuticals Ab Human monoclonal antibodies against interleukin 8 (IL-8)
US20060258841A1 (en) 2003-01-17 2006-11-16 Josef Michl Pancreatic cancer associated antigen, antibody thereto, and diagnostic and treatment methods
US7807458B2 (en) * 2003-01-30 2010-10-05 The United States Of America As Represented By The Secretary Of The Department Of Veterans Affairs Multilineage-inducible cells and uses thereof
US7456264B2 (en) 2003-05-21 2008-11-25 Medarex, Inc. Human monoclonal antibodies against Bacillus anthracis protective antigen
JO3000B1 (en) 2004-10-20 2016-09-05 Genentech Inc Antibody Formulations.
WO2006047380A2 (en) 2004-10-22 2006-05-04 Amgen, Inc. Method and media for single cell serum-fee culture of cho cells
EP1812557A4 (en) 2004-10-29 2009-11-04 Centocor Ortho Biotech Inc Chemically defined media compositions
MX2007009940A (en) * 2005-02-18 2007-10-10 Medarex Inc Monoclonal antibodies against cd30 lacking fucosyl residues.
WO2006116034A1 (en) * 2005-04-21 2006-11-02 Goldstein Glenn A N-acetylcysteine amide (nac amide) for treatment of oxidative stress associated with infertility
RU2007143302A (en) * 2005-04-22 2009-05-27 Дженентек, Инк. (Us) METHOD FOR TREATING DEMENTIA OR ALZHEIMER'S DISEASE ANTIBODIES TO CD20
WO2006125207A2 (en) 2005-05-19 2006-11-23 Amgen Inc. Compositions and methods for increasing the stability of antibodies
PE20070796A1 (en) * 2005-10-24 2007-08-15 Wyeth Corp PROTEIN PRODUCTION METHOD USING ANTI-SENESCENCE COMPOUNDS
AU2007258514A1 (en) 2006-06-09 2007-12-21 Anthrogenesis Corporation Placental niche and use thereof to culture stem cells
TW200902708A (en) * 2007-04-23 2009-01-16 Wyeth Corp Methods of protein production using anti-senescence compounds
US8697397B2 (en) 2007-08-07 2014-04-15 Chugai Seiyaku Kabushiki Kaisha Method of producing heterogeneous protein
DK2592148T3 (en) 2007-10-12 2018-12-10 Hoffmann La Roche Protein expression from multiple nucleic acids
CN101418330B (en) * 2008-06-20 2012-01-04 华东理工大学 Non protein culture medium adapted to large-scale culture of NSO cell and production of antibody
US20110229933A1 (en) * 2008-09-26 2011-09-22 SAchering Corporaton High titer antibody production
CN101603026B (en) * 2009-06-19 2011-01-19 华东理工大学 Animal origin-free low-protein culture medium suitable for animal cell product production
WO2011008770A2 (en) 2009-07-14 2011-01-20 Biogen Idec Ma Inc. Methods for inhibiting yellow color and peroxide formation in a composition
KR101822205B1 (en) 2009-08-11 2018-01-25 제넨테크, 인크. Production of proteins in glutamine-free cell culture media
WO2011134919A2 (en) 2010-04-26 2011-11-03 Novartis Ag Improved cell cultivation process
AU2011338892A1 (en) * 2010-11-05 2013-05-23 Abbvie Inc. Efficient and effective supplement screening for the development of chemically defined media in cell culture
CN102093978A (en) 2010-12-17 2011-06-15 上海市农业科学院 Prophase culture solution and anaphase culture solution for porcine early embryonic development
US20120171161A1 (en) * 2010-12-30 2012-07-05 Sascha Abramson Compositions comprising placental stem cells and platelet rich plasma, and methods of use thereof
US20130281355A1 (en) * 2012-04-24 2013-10-24 Genentech, Inc. Cell culture compositions and methods for polypeptide production
US20150267237A1 (en) * 2012-04-24 2015-09-24 Genentech, Inc. Cell culture compositions and methods for polypeptide production
WO2014029772A1 (en) 2012-08-20 2014-02-27 Schreder Method of and system for isolating led luminaires from electrical surges
BR112015021993A8 (en) 2013-03-15 2019-12-03 Genentech Inc polypeptide, methods for producing it, methods for culturing a cell, pharmaceutical composition, kit, and cell culture medium

Also Published As

Publication number Publication date
KR20210037745A (en) 2021-04-06
US10017732B2 (en) 2018-07-10
SG11201507367PA (en) 2015-10-29
BR112015021993A8 (en) 2019-12-03
SI2970875T1 (en) 2020-08-31
JP6591395B2 (en) 2019-10-16
CN105121628A (en) 2015-12-02
RU2020111947A (en) 2020-09-02
CN110951670A (en) 2020-04-03
EP3712252A1 (en) 2020-09-23
JP2019141053A (en) 2019-08-29
CA2903596C (en) 2023-10-03
PL2970875T3 (en) 2020-08-10
AU2020223634A1 (en) 2020-09-10
US10131873B2 (en) 2018-11-20
SG10201809452RA (en) 2018-11-29
US20190002822A1 (en) 2019-01-03
EP2970875B1 (en) 2020-04-15
BR112015021993A2 (en) 2017-07-18
US20140314779A1 (en) 2014-10-23
RU2015144172A (en) 2017-04-24
JP2016514461A (en) 2016-05-23
US10829732B2 (en) 2020-11-10
IL240644B (en) 2020-04-30
ES2798307T3 (en) 2020-12-10
KR102235452B1 (en) 2021-04-02
MX360779B (en) 2018-11-16
NZ751400A (en) 2021-10-29
RU2718986C2 (en) 2020-04-15
HK1218141A1 (en) 2017-02-03
US10676710B2 (en) 2020-06-09
AU2014233393A1 (en) 2015-09-10
MX2018014043A (en) 2020-11-12
ZA201805630B (en) 2019-11-27
ZA201506155B (en) 2018-11-28
NZ712315A (en) 2021-07-30
WO2014145098A1 (en) 2014-09-18
IL240644A0 (en) 2015-10-29
US20190144817A1 (en) 2019-05-16
IL273504A (en) 2020-05-31
EP2970875A1 (en) 2016-01-20
CN105121628B (en) 2020-03-24
CA2903596A1 (en) 2014-09-18
AU2022231703A1 (en) 2022-10-06
US20210017488A1 (en) 2021-01-21
US20160002593A1 (en) 2016-01-07
JP6843911B2 (en) 2021-03-17
RU2015144172A3 (en) 2018-03-12
AU2014233393B2 (en) 2020-05-28
MX2015012875A (en) 2016-02-03
HRP20200893T1 (en) 2020-09-18
KR20150131172A (en) 2015-11-24

Similar Documents

Publication Publication Date Title
IL273504A (en) Cell culture compositions with antioxidants and methods for polypeptide production
HRP20190484T1 (en) Cell culture compositions and methods for polypeptide production
IL289724A (en) Serum-free cell culture medium
IL246262A0 (en) Media for cell culture
EP2968549A4 (en) Methods of cell culture
EP2971014A4 (en) Methods of cell culture
EP2971040A4 (en) Methods of cell culture
HK1221250A1 (en) Structure for culturing cells
IL245392B (en) Cell culture method
EP3026743A4 (en) Fuel cell production method and fuel cell
GB201420277D0 (en) Cell culture system
SG11201507828VA (en) Method for culturing hepatoblast-like cells and culture product thereof
EP2964746A4 (en) Fuel cell fermentation monitor
PL2978839T3 (en) Method for cell culture
EP3003325A4 (en) Methods of evaluating cell culture additives
SG11201507338PA (en) Method for culturing cells
GB201308905D0 (en) Cell culture
GB201306488D0 (en) Cell culture
AU2013904257A0 (en) Cell culture method
AU2013900676A0 (en) Structure for culturing cells
GB201308949D0 (en) Compositions and methods for reducing methane production